Preventing neural tube defects

Pediatric Annals

Volumn 26, Issue 9, 1997, Pages 535-539

  Buehler, James W ^a   Mulinare, Joseph ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

DIET SUPPLEMENTATION; DRUG MECHANISM; HUMAN; NEURAL TUBE DEFECT; PREGNANCY; PROPHYLAXIS; REVIEW;

EID: 0030667273     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-19970901-07     Document Type: Review

References (17)

1. Centers for Disease Control. Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992;41(No. RR-14):1-7.
2. Food and Drug Administration. Folic acid fortification. Fact Sheet, February 29, 1996. Internet address: http://vm.cfsan.fda.gov/~dms/wh-folic.html.
3. Roberts HE, Moore CA, Cragan JD, Fernhoff PM, Khoury MJ. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics. 1995;96:880-883.
4. Kelly AE, Haddix AC, Scanlon KS, Helmick CG, Mulinare J. Cost effectiveness strategies to prevent neural tube defects. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:313-348.
5. Werler MM, Shapiro S, Mitchel AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993;269:1257-1261.
6. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-226.
7. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
8. Brown JE, Jacobs DR, Hartman TJ, et al. Predictors of red cell folate level in women attempting pregnancy. JAMA. 1997;277:548-552.
9. Oakley GP. Let's increase folic acid fortification and include vitamin B12. Am J Clin Nutr. 1997;65:1889-1890. Editorial.
10. Tucker KL, Mahnken B, Wilson PWF, Jacques P, Selhub J. Folic acid fortification of the food supply: potential benefits and risks for the elderly population. JAMA. 1996;276:1879-1885.
11. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
12. Steegers-Theunissen RPM, Boers FHJ, Trijbels JMT, Eskes KAB. Neural tube defects and derangements of homocysteine metabolism. N Engl J Med. 1991;324:199. Letter.
13. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. QJM. 1993;86:703-708.
14. Rozen R. Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clin Invest Med. 1996;19:171-178.
15. Posey DL. Khoury MJ, Mulinare J, Adams MJ Jr, Ou CY. Is mutated MTHFR a risk factor for neural tube defects? Lancet. 1996;347:686. Letter.
16. Johnston RB Jr. Folic acid: new dimensions of an old friendship. Adv Pediatr. 1997;44. In press.
17. American College of Obstetrics and Gynecology (ACOG). Preconceptional Care. ACOG Technical Bulletin. No. 205, May 1995.